Current Allergy and Asthma Reports

, Volume 1, Issue 2, pp 127–133 | Cite as

The bronchial epithelium in chronic and severe asthma

  • Donna E. Davies


Although patients with severe, steroid-refractory asthma represent a minor proportion of the asthmatic population, they consume a disproportionate amount of healthcare costs and have a greatly impaired quality of life. They respond poorly to conventional anti-inflammatory therapy and frequently exhibit a component of fixed airflow obstruction that has been linked to airway wall remodeling. In addition to its classic barrier function, the bronchial epithelium responds to changes in the external environment by secreting cytoprotective molecules and mediators that signal to cells of the immune system. In asthma, the bronchial epithelium is stressed and damaged, with shedding of the columnar cells into the airway lumen. This damage and ensuing repair responses are proposed to orchestrate airway inflammation and remodeling via activation of myofibroblasts in the underlying lamina reticularis. This allows the two cell types to work as a trophic unit, propagating and amplifying the response at the cell surface into the submucosa. Because wound healing involves inflammation, repair, and remodeling processes, this review considers the evidence that exaggerated inflammation and remodeling of the airways arise as a consequence of abnormal injury and repair responses coordinated by the bronchial epithelium, highlighting, where possible, steroid-insensitive components.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Serra-Batlles J, Plaza V, Morejon E, et al.: Costs of asthma according to the degree of severity. Eur Respir J 1998, 12:1322–1326.PubMedCrossRefGoogle Scholar
  2. 2.
    ENFUMOSA Study Group: Clinical, physiological and pathological features of chronic severe asthma: a multicentre European study-ENFUMOSA. Lancet 2000, submitted.Google Scholar
  3. 3.
    Montefort S, Roberts JA, Beasley R, et al.: The site of disruption of the bronchial epithelium in asthmatic and non-asthmatic subjects. Thorax 1992, 47:499–503.PubMedGoogle Scholar
  4. 4.
    Dunnill MS, Massarella GR, Anderson JA: A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis, and in emphysema. Thorax 1969, 24:176–179.PubMedCrossRefGoogle Scholar
  5. 5.
    Roche WR, Beasley R, Williams JH, Holgate ST: Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989, 1:520–524.PubMedCrossRefGoogle Scholar
  6. 6.
    Bousquet J, Jeffery PK, Busse WW, et al.: Asthma: from bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000, 161:1720–1745.PubMedGoogle Scholar
  7. 7.
    Sont JK, Willems LN, Bel EH, et al.: Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment: the AMPUL Study Group. Am J Respir Crit Care Med 1999, 159:1043–1051.PubMedGoogle Scholar
  8. 8.
    Lange P, Parner J, Vestbo J, et al.: A 15-year follow-up study of ventilatory function in adults with asthma. New Engl J Med 1998, 339:1194–1200.PubMedCrossRefGoogle Scholar
  9. 9.
    Pohunek P, Roche WR, Tarzikova J, et al.: Eosinophilic inflammation in the bronchial mucosa of children with bronchial asthma. Eur Resp J 1997, 10(suppl 25):160s.Google Scholar
  10. 10.
    The Childhood Asthma Management Program Research Group: Long-term effects of budesonide or nedocromil in children with asthma: the Childhood Asthma Management Program Research Group. New Engl J Med 2000, 343:1054–1063. This is a randomized treatment trial for more than 4 years in more than 1000 children with mild to moderate asthma. The primary outcome measure, the degree of change in forced expiratory volume in 1 second after administration of a bronchodilator, was not improved by either inhaled budesonide or nedocromil.CrossRefGoogle Scholar
  11. 11.
    Busse WW, Elias J, Sheppard D, Banks-Schlegel S: Airway remodelling and repair. Am J Respir Crit Care Med 1999, 160:1035–1042. This is an overview of airway remodeling that focuses on areas where there is need for better understanding of underlying mechanisms.PubMedGoogle Scholar
  12. 12.
    Chung KF, Godard P, Adelroth E, et al.: Difficult therapy resistant asthma: an ERS Task Force Report. Eur Respir Rev 2000, 10:1–101. This is a review of the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology, and find novel therapies.Google Scholar
  13. 13.
    Pearce N, Pekkanen J, Beasley R: How much asthma is really attributable to atopy? Thorax 1999, 54:268–272.PubMedCrossRefGoogle Scholar
  14. 14.
    Lau S, Illi S, Sommerfeld C, et al.: Early exposure to housedust mite and cat allergens and development of childhood asthma: a cohort study: Multicentre Allergy Study Group. Lancet 2000, 356:1392–1397. This is a prospective birth-cohort study of 939 of 1314 newborn infants, assessing the relevance of mite and cat allergen exposure for the development of asthma in children up to age 7 years. The paper concludes that the induction of specific IgE responses and the development of childhood asthma are determined by independent factors.PubMedCrossRefGoogle Scholar
  15. 15.
    Jansen DF, Rijcken B, Schouten JP, et al.: The relationship of skin test positivity, high serum total IgE levels, and peripheral blood eosinophilia to symptomatic and asymptomatic airway hyperresponsiveness. Am J Respir Crit Care Med 1999, 159:924–931.PubMedGoogle Scholar
  16. 16.
    Holgate ST: Genetic and environmental interaction in allergy and asthma. J Allergy Clin Immunol 1999, 104:1139–1146.PubMedCrossRefGoogle Scholar
  17. 17.
    Stein RT, Holberg CJ, Sherrill D, et al.: Influence of parental smoking on respiratory symptoms during the first decade of life: the Tucson Children’s Respiratory Study. Am J Epidemiol 1999, 149:1030–1037.PubMedGoogle Scholar
  18. 18.
    Nicolai T: Environmental air pollution and lung disease in children. Monaldi Arch Chest Dis 1999, 54:475–478.PubMedGoogle Scholar
  19. 19.
    Johnston SL, Pattemore PK, Sanderson G, et al.: The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med 1996, 154:654–660.PubMedGoogle Scholar
  20. 20.
    Holgate ST: Clinical characteristics associated to severe asthma. Am J Respir Crit Care Med 1999, 159:A700.Google Scholar
  21. 21.
    Propst SM, Denson R, Rothstein E, et al.: Proinflammatory and Th2-derived cytokines modulate CD40-mediated expression of inflammatory mediators in airway epithelia: implications for the role of epithelial CD40 in airway inflammation. J Immunol 2000, 165:2214–2221.PubMedGoogle Scholar
  22. 22.
    Dent G, Ruhlmann E, Bodtke K, et al.: Up-regulation of human eosinophil leukotriene C4 generation through contact with bronchial epithelial cells. Inflamm Res 2000, 49:236–239.PubMedCrossRefGoogle Scholar
  23. 23.
    Salvi S, Nordenhall C, Blomberg A, et al.: Diesel exhaust induces expression of IL-8 and GRO-a in bronchial epithelium in human airways. Am J Respir Crit Care Med 2000, 161:550–557.PubMedGoogle Scholar
  24. 24.
    Salvi S, Blomberg A, Rudell B, et al.: Acute inflammatory responses in the airways and peripheral blood after short-term exposure to diesel exhaust in healthy human volunteers. Am J Respir Crit Care Med 1999, 159:702–709.PubMedGoogle Scholar
  25. 25.
    Wan H, Winton HL, Soeller C, et al.: Der p 1 facilitates transepithelial allergen delivery by disruption of tight junctions. J Clin Invest 1999, 104:123–133. This is a detailed ultrastructural and biochemical analysis of the effects of the proteinase allergen Der p 1, derived from house dust mite fecal pellets on tight junction proteins. It is proposed that the allergen’s own proteolytic activity causes an increase in epithelial permeability, which facilitates transepithelial movement of Der p 1 to dendritic antigen-presenting cells via a paracellular pathway.PubMedGoogle Scholar
  26. 26.
    King C, Brennan S, Thompson PJ, Stewart GA: Dust mite proteolytic allergens induce cytokine release from cultured airway epithelium. J Immunol 1998, 161:3645–3651.PubMedGoogle Scholar
  27. 27.
    Papadopoulos NG, Bates PJ, Bardin PG, et al.: Rhinoviruses infect the lower airways. J Infect Dis 2000, 181:1875–1884.PubMedCrossRefGoogle Scholar
  28. 28.
    Grunberg K, Sharon RF, Hiltermann TJ, et al.: Experimental rhinovirus 16 infection increases intercellular adhesion molecule-1 expression in bronchial epithelium of asthmatics regardless of inhaled steroid treatment. Clin Exp Allergy 2000, 30:1015–1023.PubMedCrossRefGoogle Scholar
  29. 29.
    Hart LA, Krishnan VL, Adcock IM, et al.: Activation and localization of transcription factor, nuclear factor-kappaB, in asthma. Am J Respir Crit Care Med 1998, 158:1585–1592.PubMedGoogle Scholar
  30. 30.
    Holgate ST, Lackie PM, Davies DE, et al.: The bronchial epithelium as a key regulator of airway inflammation and remodelling in asthma. Clin Exp Allergy 1999, 29(suppl 2):90–95.PubMedCrossRefGoogle Scholar
  31. 31.
    Bucchieri F, Lordan J, Richter D, et al.: Increased sensitivity of asthmatic bronchial epithelial cells to oxidant-induced injury. Am J Respir Crit Care Med 2000, 161:A153.Google Scholar
  32. 32.
    Bayram H, Devalia JL, Khair OA, et al.: Comparison of ciliary activity and inflammatory mediator release from bronchial epithelial cells of nonatopic nonasthmatic subjects and atopic asthmatic patients and the effect of diesel exhaust particles in vitro. J Allergy Clin Immunol 1998, 102:771–782.PubMedCrossRefGoogle Scholar
  33. 33.
    Seaton A, Devereux G: Diet, infection and wheezy illness: lessons from adults. Pediatr Allergy Immunol 2000, 11(suppl 13):37–40.PubMedCrossRefGoogle Scholar
  34. 34.
    Jeffery PK: Differences and similarities between chronic obstructive pulmonary disease and asthma. Clin Exp Allergy 1999, 29(suppl 2):14–26.PubMedGoogle Scholar
  35. 35.
    Ordonez CL, Shaughnessy TE, Matthay MA, Fahy JV: Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma: clinical and biologic significance. Am J Respir Crit Care Med 2000, 161:1185–1190.PubMedGoogle Scholar
  36. 36.
    Jeffery PK, Wardlaw AJ, Nelson FC, et al.: Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis 1989, 140:1745–1753.PubMedGoogle Scholar
  37. 37.
    Puddicombe SM, Polosa R, Richter A, et al.: The involvement of the epidermal growth factor receptor in epithelial repair in asthma. FASEB J 2000, 14:1362–1374. This paper provides new evidence that the asthmatic bronchial epithelium is injured in vivo and identifies the EGFR pathway as steroid unresponsive. A paradigm linking impaired repair and remodeling is proposed.PubMedCrossRefGoogle Scholar
  38. 38.
    Davies DE, Polosa R, Puddicombe SM, et al.: The epidermal growth factor receptor and its ligand family: their potential role in repair and remodelling in asthma. Allergy 1999, 54:771–783.PubMedGoogle Scholar
  39. 39.
    Torres-Lozano C, Puddicombe SM, Howarth PH, et al.: Expression of the cell cycle inhibitor, p21waf, is higher in the bronchial epithelium of severe asthmatic subjects. Am J Respir Crit Care Med 2000, 161:A260.Google Scholar
  40. 40.
    Demoly P, Simony-Lafontaine J, Chanez P, et al.: Cell proliferation in the bronchial mucosa of asthmatics and chronic bronchitics. Am J Respir Crit Care Med 1994, 150:214–217.PubMedGoogle Scholar
  41. 41.
    Hartsough MT, Mulder KM: Transforming growth factor-beta signaling in epithelial cells. Pharmacol Ther 1997, 75:21–41.PubMedCrossRefGoogle Scholar
  42. 42.
    Vignola AM, Chanez P, Chiappara G, et al.: Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med 1997, 156:591–599.PubMedGoogle Scholar
  43. 43.
    Polosa R, Krishna MT, Tuck PH, et al.: Profile of c-erbB receptor expression in bronchial asthma and in epithelial repair. Am J Respir Crit Care Med 2000, 161:A777.Google Scholar
  44. 44.
    Koch A, Ito K, Tomita K, et al.: Phosphorylation of mitogen activated protein kinases p44ERK1 and p42ERK2 in bronchial biopsies from asthmatic and normal subjects-effect of theophylline. Am J Respir Crit Care Med 2000, 161:A742.Google Scholar
  45. 45.
    Gorospe M, Wang X, Holbrook NJ: Functional role of p21 during the cellular response to stress. Gene Expr 1999, 7:377–385.PubMedGoogle Scholar
  46. 46.
    Cha HH, Cram EJ, Wang EC, et al.: Glucocorticoids stimulate p21 gene expression by targeting multiple transcriptional elements within a steroid responsive region of the p21waf1/ cip1 promoter in rat hepatoma cells. J Biol Chem 1998, 273:1998–2007.PubMedCrossRefGoogle Scholar
  47. 47.
    Brewster CE, Howarth PH, Djukanovic R, et al.: Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 1990, 3:507–511.PubMedGoogle Scholar
  48. 48.
    Evans MJ, van Winkle LS, Fanucchi MV, Plopper CG: The attenuated fibroblast sheath of the respiratory tract epithelial-mesenchymal trophic unit. Am J Respir Cell Mol Biol 1999, 21:655–657.PubMedGoogle Scholar
  49. 49.
    Zhang S, Smartt H, Holgate ST, Roche WR: Growth factors secreted by bronchial epithelial cells control myofibroblast proliferation: an in vitro co-culture model of airway remodeling in asthma. Lab Invest 1999, 79:395–405.PubMedGoogle Scholar
  50. 50.
    Sime PJ, Xing Z, Graham FL, et al.: Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. J Clin Invest 1997, 100:768–776.PubMedCrossRefGoogle Scholar
  51. 51.
    Puddicombe SM, Richter A, Djukanovic R, et al.: The epithelial mesenchymal trophic unit in asthma. Am J Respir Crit Care Med 2000, 161:A259.Google Scholar
  52. 52.
    Richter A, Puddicombe SM, Lordan J, et al.: The contribution of interleukin-4 and interleukin-13 on the epithelialmesenchymal trophic unit in asthma. Am J Respir Cell Mol Biol 2000, submitted.Google Scholar
  53. 53.
    Hoshino M, Nakamura Y, Sim JJ, et al.: Inhaled corticosteroid reduced lamina reticularis of the basement membrane by modulation of insulin-like growth factor (IGF)-I expression in bronchial asthma. Clin Exp Allergy 1998, 28:568–577.PubMedCrossRefGoogle Scholar
  54. 54.
    Warburton D, Schwarz M, Tefft D, et al.: The molecular basis of lung morphogenesis. Mech Dev 2000, 92:55–81.PubMedCrossRefGoogle Scholar
  55. 55.
    Holgate ST, Davies DE, Lackie PM, et al.: Epithelialmesenchymal interactions in the pathogenesis of asthma. J Allergy Clin Immunol 2000, 105:193–204. This is a review of the concept of the EMTU in asthma.PubMedCrossRefGoogle Scholar
  56. 56.
    Stick S: The contribution of airway development to paediatric and adult lung disease. Thorax 2000, 55:587–594.PubMedCrossRefGoogle Scholar
  57. 57.
    Sekhon HS, Keller JA, Spindel ER: Maternal nicotine exposure up-regulates collagen and elastin gene expression in fetal nonhuman primate lungs. Am J Respir Crit Care Med 2000, 161:A562.Google Scholar
  58. 58.
    Mauderly JL, Bice DE, Carpenter RL, et al.: Effects of inhaled nitrogen dioxide and diesel exhaust on developing lung. Res Rep Health Eff Inst 1987, 8:3–37.PubMedGoogle Scholar

Copyright information

© Current Science Inc. 2001

Authors and Affiliations

  • Donna E. Davies
    • 1
  1. 1.Respiratory, Cell & Molecular Biology Division, School of MedicineUniversity of Southampton, Level D Centre Block, Southampton General HospitalSouthamptonUK

Personalised recommendations